An Analysis of Pharmaceutical Lending by the World Bank
The World Bank (WB) began to lend for health, nutrition, and population (HNP) in the late 1970s. Today, the Bank has become the single largest external source of HNP financing in low- and middle-income countries. The Bank's activities in the H...
| Main Authors: | , |
|---|---|
| Format: | Working Paper |
| Language: | English en_US |
| Published: |
World Bank, Washington, DC
2013
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/2004/09/5621115/analysis-pharmaceutical-lending-world-bank http://hdl.handle.net/10986/13730 |
| id |
okr-10986-13730 |
|---|---|
| recordtype |
oai_dc |
| spelling |
okr-10986-137302021-04-23T14:03:09Z An Analysis of Pharmaceutical Lending by the World Bank Rodríguez-Monguió, Rosa Rovira, Juan ANTIBIOTICS APPRAISAL REPORTS BORROWER COMPETITIVE BIDDING CONCESSIONAL LOANS CONTRACEPTIVES COST ACCOUNTING DEVELOPMENT GOALS DRUGS ECONOMICS EXPENDITURES FISCAL YEAR FOREIGN EXCHANGE HEALTH CARE HEALTH SECTOR HEALTH SERVICES HOSPITALS HUMAN CAPITAL INCOME LEGISLATION LENDING DOCUMENTS LENDING INSTRUMENTS LENDING OPERATIONS LOAN LOAN AGREEMENTS MEDICAL SUPPLIES MEDICINE NUTRITION PHARMACEUTICAL PRODUCTS PHARMACEUTICAL SECTOR PHARMACEUTICAL SUPPLIERS PHARMACEUTICALS PRIVATE SECTOR PROCUREMENT PROJECT IMPLEMENTATION PUBLIC HEALTH PUBLIC POLICIES PURCHASING RATIONAL USE OF DRUGS SANITATION SUPPLIERS TECHNICAL ASSISTANCE TRANSPARENCY TRUST FUNDS VACCINES VENEZUELA WATER SUPPLY LENDING LENDING OPERATIONS The World Bank (WB) began to lend for health, nutrition, and population (HNP) in the late 1970s. Today, the Bank has become the single largest external source of HNP financing in low- and middle-income countries. The Bank's activities in the HNP sector are based on the rationale that investments in health, nutrition, and population constitute an investment in human capital that is necessary for enhanced welfare, reduced poverty and sustainable growth. During fiscal years (FY) 1999 to 2002, the World Bank approved 683 lending projects in all sectors, with a total lending amount of US$ 38,306 million (2001 prices). During the same period of time, the World Bank approved 65 HNP lending projects, with a total cumulative value of US$ 3,298 million (2001 prices). The Bank has been financing pharmaceutical activities within the HNP portfolio since 1983. In total, the Bank has provided financing for pharmaceuticals in over 100 HNP projects in all six regions. According to the results of the present research, contracts for the procurement of pharmaceuticals and medical products (PMP) under Bank financed projects from FY 1999 to FY 2002 accounted for almost 36 percent of the procurement of goods in HNP, and for 18 percent of the total HNP procurement activity including goods, civil works, consulting and other services. Despite the increased interest in pharmaceuticals, lending in this area has been conducted without the guidance of an explicit operational policy on pharmaceuticals. While the World Bank has produced a number of policy papers and reports on pharmaceuticals, these are not considered operational policy. In this situation, good practices and implicit policy guide the pharmaceutical activities of the HNP sector and the Bank's pharmaceutical activities. 2013-05-30T20:57:16Z 2013-05-30T20:57:16Z 2004-09 http://documents.worldbank.org/curated/en/2004/09/5621115/analysis-pharmaceutical-lending-world-bank http://hdl.handle.net/10986/13730 English en_US Health, Nutrition and Population (HNP) discussion paper; CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo/ World Bank World Bank, Washington, DC Publications & Research :: Working Paper Publications & Research |
| repository_type |
Digital Repository |
| institution_category |
Foreign Institution |
| institution |
Digital Repositories |
| building |
World Bank Open Knowledge Repository |
| collection |
World Bank |
| language |
English en_US |
| topic |
ANTIBIOTICS APPRAISAL REPORTS BORROWER COMPETITIVE BIDDING CONCESSIONAL LOANS CONTRACEPTIVES COST ACCOUNTING DEVELOPMENT GOALS DRUGS ECONOMICS EXPENDITURES FISCAL YEAR FOREIGN EXCHANGE HEALTH CARE HEALTH SECTOR HEALTH SERVICES HOSPITALS HUMAN CAPITAL INCOME LEGISLATION LENDING DOCUMENTS LENDING INSTRUMENTS LENDING OPERATIONS LOAN LOAN AGREEMENTS MEDICAL SUPPLIES MEDICINE NUTRITION PHARMACEUTICAL PRODUCTS PHARMACEUTICAL SECTOR PHARMACEUTICAL SUPPLIERS PHARMACEUTICALS PRIVATE SECTOR PROCUREMENT PROJECT IMPLEMENTATION PUBLIC HEALTH PUBLIC POLICIES PURCHASING RATIONAL USE OF DRUGS SANITATION SUPPLIERS TECHNICAL ASSISTANCE TRANSPARENCY TRUST FUNDS VACCINES VENEZUELA WATER SUPPLY LENDING LENDING OPERATIONS |
| spellingShingle |
ANTIBIOTICS APPRAISAL REPORTS BORROWER COMPETITIVE BIDDING CONCESSIONAL LOANS CONTRACEPTIVES COST ACCOUNTING DEVELOPMENT GOALS DRUGS ECONOMICS EXPENDITURES FISCAL YEAR FOREIGN EXCHANGE HEALTH CARE HEALTH SECTOR HEALTH SERVICES HOSPITALS HUMAN CAPITAL INCOME LEGISLATION LENDING DOCUMENTS LENDING INSTRUMENTS LENDING OPERATIONS LOAN LOAN AGREEMENTS MEDICAL SUPPLIES MEDICINE NUTRITION PHARMACEUTICAL PRODUCTS PHARMACEUTICAL SECTOR PHARMACEUTICAL SUPPLIERS PHARMACEUTICALS PRIVATE SECTOR PROCUREMENT PROJECT IMPLEMENTATION PUBLIC HEALTH PUBLIC POLICIES PURCHASING RATIONAL USE OF DRUGS SANITATION SUPPLIERS TECHNICAL ASSISTANCE TRANSPARENCY TRUST FUNDS VACCINES VENEZUELA WATER SUPPLY LENDING LENDING OPERATIONS Rodríguez-Monguió, Rosa Rovira, Juan An Analysis of Pharmaceutical Lending by the World Bank |
| relation |
Health, Nutrition and Population (HNP)
discussion paper; |
| description |
The World Bank (WB) began to lend for
health, nutrition, and population (HNP) in the late 1970s.
Today, the Bank has become the single largest external
source of HNP financing in low- and middle-income countries.
The Bank's activities in the HNP sector are based on
the rationale that investments in health, nutrition, and
population constitute an investment in human capital that is
necessary for enhanced welfare, reduced poverty and
sustainable growth. During fiscal years (FY) 1999 to 2002,
the World Bank approved 683 lending projects in all sectors,
with a total lending amount of US$ 38,306 million (2001
prices). During the same period of time, the World Bank
approved 65 HNP lending projects, with a total cumulative
value of US$ 3,298 million (2001 prices). The Bank has been
financing pharmaceutical activities within the HNP portfolio
since 1983. In total, the Bank has provided financing for
pharmaceuticals in over 100 HNP projects in all six regions.
According to the results of the present research, contracts
for the procurement of pharmaceuticals and medical products
(PMP) under Bank financed projects from FY 1999 to FY 2002
accounted for almost 36 percent of the procurement of goods
in HNP, and for 18 percent of the total HNP procurement
activity including goods, civil works, consulting and other
services. Despite the increased interest in pharmaceuticals,
lending in this area has been conducted without the guidance
of an explicit operational policy on pharmaceuticals. While
the World Bank has produced a number of policy papers and
reports on pharmaceuticals, these are not considered
operational policy. In this situation, good practices and
implicit policy guide the pharmaceutical activities of the
HNP sector and the Bank's pharmaceutical activities. |
| format |
Publications & Research :: Working Paper |
| author |
Rodríguez-Monguió, Rosa Rovira, Juan |
| author_facet |
Rodríguez-Monguió, Rosa Rovira, Juan |
| author_sort |
Rodríguez-Monguió, Rosa |
| title |
An Analysis of Pharmaceutical Lending by the World Bank |
| title_short |
An Analysis of Pharmaceutical Lending by the World Bank |
| title_full |
An Analysis of Pharmaceutical Lending by the World Bank |
| title_fullStr |
An Analysis of Pharmaceutical Lending by the World Bank |
| title_full_unstemmed |
An Analysis of Pharmaceutical Lending by the World Bank |
| title_sort |
analysis of pharmaceutical lending by the world bank |
| publisher |
World Bank, Washington, DC |
| publishDate |
2013 |
| url |
http://documents.worldbank.org/curated/en/2004/09/5621115/analysis-pharmaceutical-lending-world-bank http://hdl.handle.net/10986/13730 |
| _version_ |
1764424221379788800 |